AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-77
Results: 51-75/77

Authors: Schroder, FH
Citation: Fh. Schroder, Endocrine treatment of prostate cancer - recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side-effects, BJU INT, 83(2), 1999, pp. 161-170

Authors: Blijenberg, BG Storm, BN Kruger, AEB Schroder, FH
Citation: Bg. Blijenberg et al., On the standardization of total prostate-specific antigen: an exercise with two reference preparations, CLIN CH L M, 37(5), 1999, pp. 545-552

Authors: Verkoelen, CF Van der Boom, BG Kok, DJ Schroder, FH Romijn, JC
Citation: Cf. Verkoelen et al., Attachment sites for particles in the urinary tract, J AM S NEPH, 10, 1999, pp. S430-S435

Authors: van Brussel, JP van Steenbrugge, GJ Romijn, JC Schroder, FH Mickisch, GHJ
Citation: Jp. Van Brussel et al., Chemosensitivity of prostate cancer cell lines and expression of multidrugresistance-related proteins, EUR J CANC, 35(4), 1999, pp. 664-671

Authors: Alexander, FE Andriole, GL Aus, G Auvinen, A Beensterboer, P Blijenberg, BG Bonardi, R Buys, S Candas, B Ciatto, S Crawford, ED Demers, R de Koning, HJ Denis, L Dijk, MA Figueiredo, F Gellman, EP Gohagan, J Hakama, M Hugosson, J Kirkels, WI Kranse, R van der Kwast, TH Lilja, H Maattanen, L Mandel, J Miller, AB Monteiro, H Nelen, V Oberman, A Paez, A Prorok, PC Reding, D Rietbergen, JWBW Rose, DB Sanchez, AB Schroder, FH da Silva, EC Simpson, N Smith, PH Stadaert, B Stenman, UH Teppo, L Turkes, A Weissfeld, JL Yokochi, L
Citation: Fe. Alexander et al., Rationale for randomised trials of prostate cancer screening, EUR J CANC, 35(2), 1999, pp. 262-271

Authors: Blom, JHM van Poppel, H Marechal, JM Jacqmin, D Sylvester, R Schroder, FH de Prijck, L
Citation: Jhm. Blom et al., Radical nephrectomy with and without lymph node dissection: Preliminary results of the EORTC randomized phase III protocol 30881, EUR UROL, 36(6), 1999, pp. 570-575

Authors: Schroder, FH Kranse, R Rietbergen, J Hoedemaeker, R Kirkels, W
Citation: Fh. Schroder et al., The European Randomized Study of Screening for Prostate Cancer (ERSBC): Anupdate, EUR UROL, 35(5-6), 1999, pp. 539-543

Authors: Verkoelen, CF Kok, DJ van der Boom, BG de Jonge, HR Schroder, FH Romijn, JC
Citation: Cf. Verkoelen et al., LLC-PK1 cells as a model system to study proximal tubule transport of water and other compounds relevant for renal stone disease, UROL RES, 27(2), 1999, pp. 109-115

Authors: de Water, R Noordermeer, C van der Kwast, TH Nizze, H Boeve, ER Kok, DJ Schroder, FH
Citation: R. De Water et al., Calcium oxalate nephrolithiasis: Effect of renal crystal deposition on thecellular composition of the renal interstitium, AM J KIDNEY, 33(4), 1999, pp. 761-771

Authors: Hegarty, NJ Fitzpatrick, JM Richie, JP Scardino, PT White, RWD Schroder, FH Coffey, DS
Citation: Nj. Hegarty et al., Future prospects in prostate cancer, PROSTATE, 40(4), 1999, pp. 261-268

Authors: Beemsterboer, PMM de Koning, HJ Birnie, E van der Maas, PJ Schroder, FH
Citation: Pmm. Beemsterboer et al., Advanced prostate cancer: Course, care, and cost implications, PROSTATE, 40(2), 1999, pp. 97-104

Authors: Boer, R Schroder, FH
Citation: R. Boer et Fh. Schroder, Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction, PROSTATE, 40(2), 1999, pp. 130-131

Authors: Kranse, R Beemsterboer, P Rietbergen, J Habbema, D Hugosson, J Schroder, FH
Citation: R. Kranse et al., Predictors for biopsy outcome in the European randomized study of screening for prostate cancer (Rotterdam region), PROSTATE, 39(4), 1999, pp. 316-322

Authors: Verkoelen, CF van der Boom, BG Kok, DJ Houtsmuller, AB Visser, P Schroder, FH Romijn, JC
Citation: Cf. Verkoelen et al., Cell type-specific acquired protection from crystal adherence by renal tubule cells in culture, KIDNEY INT, 55(4), 1999, pp. 1426-1433

Authors: Dubbink, HJ Hoedemaeker, RF van der Kwast, TH Schroder, FH Romijn, JC
Citation: Hj. Dubbink et al., Human prostate-specific transglutaminase: A new prostatic marker with a unique distribution pattern, LAB INV, 79(2), 1999, pp. 141-150

Authors: Rietbergen, JBW Hoedemaeker, RF Kruger, AEB Kirkels, WJ Schroder, FH
Citation: Jbw. Rietbergen et al., The changing pattern of prostate cancer at the time of diagnosis: Characteristics of screen detected prostate cancer in a population based screening study, J UROL, 161(4), 1999, pp. 1192-1198

Authors: Noordzij, MA van Steenbrugge, GJ Schroder, FH Van der Kwast, TH
Citation: Ma. Noordzij et al., Decreased expression of CD44 in metastatic prostate cancer, INT J CANC, 84(5), 1999, pp. 478-483

Authors: Beemsterboer, PMM Kranse, R de Koning, HJ Habbema, JDF Schroder, FH
Citation: Pmm. Beemsterboer et al., Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam), INT J CANC, 84(4), 1999, pp. 437-441

Authors: Blijenberg, BG Storm, BN Van Zelst, BD Kruger, AEB Schroder, FH
Citation: Bg. Blijenberg et al., New developments in the standardization of total prostate-specific antigen, CLIN BIOCH, 32(8), 1999, pp. 627-634

Authors: Hoedemaeker, RF Kranse, R Rietbergen, JBW Kruger, AEB Schroder, FH van der Kwast, TH
Citation: Rf. Hoedemaeker et al., Evaluation of prostate needle biopsies in a population-based screening study - The impact of borderline lesions, CANCER, 85(1), 1999, pp. 145-152

Authors: Jongsma, J Oomen, MH Noordzij, MA Van Weerden, WM Martens, GJM van der Kwast, TH Schroder, FH van Steenbrugge, GJ
Citation: J. Jongsma et al., Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model, AM J PATH, 154(2), 1999, pp. 543-551

Authors: Schroder, FH
Citation: Fh. Schroder, Prostate cancer, BAS CLIN ON, 18, 1999, pp. 461-514

Authors: Schroder, FH van der Maas, P Beemsterboer, P Kruger, AB Hoedemaeker, R Rietbergen, J Kranse, R
Citation: Fh. Schroder et al., Evaluation of the digital rectal examination as a screening test for prostate cancer, J NAT CANC, 90(23), 1998, pp. 1817-1823

Authors: Schroder, FH Lilja, H Abrahamsson, PA Schalken, J Lovgren, T Pettersson, K
Citation: Fh. Schroder et al., Markers for prostate cancer, BIOM HLTH R, 24, 1998, pp. 245-253

Authors: de Koning, HJ Schroder, FH
Citation: Hj. De Koning et Fh. Schroder, PSA screening for prostate cancer: The current controversy, ANN ONCOL, 9(12), 1998, pp. 1293-1296
Risultati: 1-25 | 26-50 | 51-75 | 76-77